Dignicap Scalp Cooling System, breast cancer, chemotherapy

Scalp Cooling Device Prevents Hair Loss

By MedTech Intelligence Staff
3 Comments
Dignicap Scalp Cooling System, breast cancer, chemotherapy

Women being treated with chemotherapy for breast cancer may be able to benefit from the new technology.

This article was part of our April Fool’s edition. 57% of poll participants guessed that this story was a hoax. Well guess what? This technology is the REAL DEAL. It’s called DigniCap.

A scalp cooling system has been shown to reduce chemotherapy-induced hair loss in women with breast cancer. In an FDA clinical trial involving the technology, seven out of 10 early-stage breast cancer patients kept at least 50% of their hair.

The system consists of a silicone cooling cap that fits snug on the head, along with an outer neoprene cap to insulate and secure the silicone cap, which is connected to a cooling and control unit. When operating, a liquid coolant circulates throughout the cap to provide controlled cooling to the scalp.

As the temperature of the scalp is lowered, vasoconstriction occurs, resulting in a lower rate of chemotherapy delivery to the scalp and a decreased intra-follicular metabolic rate, thereby reducing cellular drug uptake.

“We are very excited to be the first oncology practice in the area to provide the system to our breast cancer patients. Losing hair during chemotherapy can be a devastating experience and no woman should have to go through such physical and emotional trauma in this day and age,” said Dr. Young Lee from Chesapeake Oncology & Hematology COHA, in a company press release. “In the past, we have used different types of scalp cooling caps that were very cumbersome and labor intensive.”

The system will be initially rolled out at 10 cancer treatment centers in the south and in California.

Related Articles

  • Unannounced Audits

    Critical subcontractors and crucial suppliers will be subject to unannounced audits by notified bodies under the revised European device regulations. Richard DeRisio of TÜV Süd provides more details in this presentation.

  • Supplier Responsibility in Medical Device Recalls

    What is the responsibility of the design owner? What level of accountability does the supplier have? What follow-up actions must a supplier take? A variety of best practices need to be driven forward by both suppliers and OEMs in an…

  • J&J Device Sales Fall

    The healthcare giant reported worldwide medical devices sales of $27.5 billion for the full-year 2014, a decrease of 3.4 percent versus the prior year.

  • Medical Device Supplier Certification: the Rx-360 Approach

    Rx-360, an international pharmaceutical supply chain consortium, which helps its members share best practices to ensure the integrity of the healthcare supply chain, is now gearing for growth in the device space. What lessons can device makers learn?

Comments

  1. James Allen

    I never hear about this method before until now. Does method use for cancer patients only or it can apply to anyone who has problem with hair loss? Nice technic, hope it more popular soon

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

If you agree to these terms, please click here.